Lv1
10 积分 2025-04-10 加入
Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
3个月前
已完结
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis
3个月前
已完结
‘I don’t worry about going outside anymore’: a patient’s journey with recalcitrant lupus pernio responsive to adalimumab
3个月前
已关闭
Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease
3个月前
已完结
Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease
3个月前
已完结
Potential Predictors of Biological Therapy Intensification in Moderate‐To‐Severe Hidradenitis Suppurativa: A Multicentre Study
3个月前
已完结
Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma
4个月前
已关闭
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
6个月前
已完结
Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis
6个月前
已完结
Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer
6个月前
已关闭
皖公网安备34019202002308
